• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    FlexShopper And 3 Other Stocks Under $5 Insiders Are Buying

    6/10/24 9:01:39 AM ET
    $AIRI
    $EZFL
    $FPAY
    $HBIO
    Military/Government/Technical
    Industrials
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary
    Get the next $AIRI alert in real time by email

    The Dow Jones index closed lower by around 0.2% on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

    Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.

    Harvard Bioscience

    • The Trade: Harvard Bioscience, Inc. (NASDAQ:HBIO) CEO James W Green bought a total of 20,000 shares at an average price of $3.07. To acquire these shares, it cost around $61,400.
    • What's Happening: On May 7, Harvard Bioscience posted weaker-than-expected quarterly sales.
    • What Harvard Bioscience Does: Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development.

    EZFill Holdings

    • The Trade: EZFill Holdings Inc. (NASDAQ:EZFL) 10% owner Michael D Farkas acquired a total of 10,000 shares at an average price of $2.10. To acquire these shares, it cost around $20,985.
    • What's Happening: On May 15, EzFill Holdings posted a narrower loss  for the first quarter.
    • What EZFill Holdings Does: EzFill Holdings Inc is an application-based on-demand fuel delivery company in Florida and a mobile fueling company that combines on-demand fills and subscription services that fill customer vehicles on routine intervals.

    Check This Out: Top 4 Tech Stocks That May Explode This Month

    Air Industries Group

    • The Trade: Air Industries Group (NYSE:AIRI) President Luciano M Melluzzo acquired a total of 11,082 shares at an average price of $3.64. The insider spent around $40,283 to buy those shares.
    • What's Happening: On May 15, Air Industries Group reported better-than-expected first-quarter sales results.
    • What Air Industries Group Does: Air Industries Group is an aerospace and defense company.

    FlexShopper

    • The Trade: FlexShopper, Inc. (NASDAQ:FPAY) Director Howard Dvorkin acquired a total of 75,346 shares at an average price of $1.10. The insider spent around $83,112 to buy those shares.
    • What's Happening: On May 13, FlexShopper posted upbeat quarterly sales.
    • What FlexShopper Does: FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers.

    Don’t forget to check out our premarket coverage here

    Get the next $AIRI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIRI
    $EZFL
    $FPAY
    $HBIO

    CompanyDatePrice TargetRatingAnalyst
    Harvard Bioscience Inc.
    $HBIO
    4/9/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    Harvard Bioscience Inc.
    $HBIO
    3/10/2023$3.00 → $4.00Speculative Buy → Buy
    The Benchmark Company
    More analyst ratings

    $AIRI
    $EZFL
    $FPAY
    $HBIO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Harvard Biosci downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Harvard Biosci from Overweight to Sector Weight

    4/9/25 8:35:36 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Harvard Biosci upgraded by The Benchmark Company with a new price target

    The Benchmark Company upgraded Harvard Biosci from Speculative Buy to Buy and set a new price target of $4.00 from $3.00 previously

    3/10/23 8:11:48 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    KeyCorp reiterated coverage on Harvard Bioscience with a new price target

    KeyCorp reiterated coverage of Harvard Bioscience with a rating of and set a new price target of $9.00 from $6.00 previously

    3/10/21 5:04:31 PM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AIRI
    $EZFL
    $FPAY
    $HBIO
    SEC Filings

    View All

    Air Industries Group filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure

    8-K - AIR INDUSTRIES GROUP (0001009891) (Filer)

    2/17/26 7:01:47 AM ET
    $AIRI
    Military/Government/Technical
    Industrials

    Air Industries Group filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - AIR INDUSTRIES GROUP (0001009891) (Filer)

    2/17/26 7:00:45 AM ET
    $AIRI
    Military/Government/Technical
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Harvard Bioscience Inc.

    SCHEDULE 13G/A - HARVARD BIOSCIENCE INC (0001123494) (Subject)

    2/12/26 11:27:18 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AIRI
    $EZFL
    $FPAY
    $HBIO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tenax Aerospace and Air Industries Group Announce Strategic Combination to Form Scaled Aerospace and Defense Platform

    Combination brings together special mission aviation and precision aerospace manufacturing to create a diversified mid-cap company expected to remain listed on NYSE American Tenax Aerospace Acquisition, LLC ("Tenax") and Air Industries Group ("Air") (NYSE:AIRI) jointly announced today that they have entered into an Agreement and Plan of Merger ("Merger Agreement") to combine Tenax's special mission aviation business with Air's precision aerospace manufacturing business. The merging of the companies will create a larger and more diversified company well-positioned to serve the needs of their government and commercial customers. After the merger, the combined company expects to remain liste

    2/17/26 7:01:00 AM ET
    $AIRI
    Military/Government/Technical
    Industrials

    Air Industries Group Announces Preliminary Unaudited Results for 2025

    Air Industries Group (NYSE:AIRI), a leading manufacturer of precision components and assemblies for large aerospace and defense prime contractors, today announced preliminary unaudited results for the year ended December 31, 2025. Consolidated sales were approximately $47.9 million Gross profit of $8.1 million or approximately 17.1% Loss from operations of approximately $334,000 Net loss of approximately $1.3 million Adjusted EBITDA (as calculated below) of approximately $4.3 million Reconciliation of Adjusted EBITDA to GAAP     PRELIMINARY AND UNAUDITED     For the Year Ended December 31, 2025 Net (Loss)   $ (1,305,000 ) Intere

    2/17/26 7:00:00 AM ET
    $AIRI
    Military/Government/Technical
    Industrials

    Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas

    Reports preliminary fourth quarter revenue in line with guidance, gross margin at high end of guidance, and strong year over year adjusted EBITDA performance Expects year over year revenue growth and mid-to high-single-digit EBITDA growth in 2026Outlines strategy focused on positioning the company as a leader in the growing translational science tools market while expanding consumables revenue and improving operational performance HOLLISTON, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience"), a global leader in life science research tools, today announced preliminary financial results for the fourth quarter ended Decembe

    2/10/26 7:30:00 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AIRI
    $EZFL
    $FPAY
    $HBIO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Taglich Robert

    4 - AIR INDUSTRIES GROUP (0001009891) (Issuer)

    2/17/26 7:13:37 AM ET
    $AIRI
    Military/Government/Technical
    Industrials

    SEC Form 4 filed by Director Taglich Michael N

    4 - AIR INDUSTRIES GROUP (0001009891) (Issuer)

    2/17/26 7:11:34 AM ET
    $AIRI
    Military/Government/Technical
    Industrials

    SEC Form 4 filed by Director Brand Michael

    4 - AIR INDUSTRIES GROUP (0001009891) (Issuer)

    2/17/26 7:09:40 AM ET
    $AIRI
    Military/Government/Technical
    Industrials

    $AIRI
    $EZFL
    $FPAY
    $HBIO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dvorkin Howard bought $168,555 worth of shares (128,668 units at $1.31) (SEC Form 4)

    4 - FlexShopper, Inc. (0001397047) (Issuer)

    5/5/25 8:12:05 PM ET
    $FPAY
    Diversified Commercial Services
    Consumer Discretionary

    Director Dvorkin Howard bought $39,823 worth of shares (30,729 units at $1.30) (SEC Form 4)

    4 - FlexShopper, Inc. (0001397047) (Issuer)

    4/30/25 4:01:26 PM ET
    $FPAY
    Diversified Commercial Services
    Consumer Discretionary

    Director Dvorkin Howard bought $30,000 worth of shares (20,000 units at $1.50) (SEC Form 4)

    4 - FlexShopper, Inc. (0001397047) (Issuer)

    12/30/24 4:01:16 PM ET
    $FPAY
    Diversified Commercial Services
    Consumer Discretionary

    $AIRI
    $EZFL
    $FPAY
    $HBIO
    Leadership Updates

    Live Leadership Updates

    View All

    Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package

    Completes Repayment of Existing Credit Agreement, Extends Debt Maturity, and Enhances Financial FlexibilityBroadOak Partner Bill Snider to Join Board of Directors and Company to Form Advisory Board on Growth and Operating Opportunities  HOLLISTON, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience"), today announced it entered into an agreement with BroadOak Capital Partners (collectively, "BroadOak"), a life-sciences-focused investment and advisory firm, to provide a $40 million credit facility comprised of three term loans, all of which will be funded on December 17, 2025. The proceeds of the facility will be used to ret

    12/17/25 7:30:00 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors

    HOLLISTON, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience") today announced the appointment of Stephen DeNelsky to its Board of Directors, effective September 5, 2025. Mr. DeNelsky will also serve on the Board's Nominating and Governance Committee. "We are pleased to announce Steve as the newest member of our Board of Directors at such an important time for Harvard Bioscience," said John Duke, President & CEO. "His knowledge across the verticals we operate in, as well as his expertise in guiding life sciences companies on financial strategy will be invaluable as we move forward." "I'm honored to join the Board and lo

    9/9/25 7:00:00 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board

    Current Board member John Duke to succeed Jim Green as President & CEO Rob Gagnon and Seth Benson appointed as new Board membersQ2 '25 revenue anticipated to be $20.4 million and Company reiterates previously announced Q2 ‘25 gross margin guidance HOLLISTON, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience") today announced a CEO succession plan under which John Duke will assume the role of President & CEO following the planned retirement of Jim Green, effective July 28, 2025. Jim Green will be retiring from his President, CEO & Chairman roles at Harvard Bioscience after more than 8 years as Chairman and 6 years as Pre

    7/17/25 7:00:00 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AIRI
    $EZFL
    $FPAY
    $HBIO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Harvard Bioscience Inc.

    SC 13G/A - HARVARD BIOSCIENCE INC (0001123494) (Subject)

    11/14/24 12:31:23 PM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SC 13D/A filed by EzFill Holdings Inc.

    SC 13D/A - EzFill Holdings Inc (0001817004) (Subject)

    8/29/24 5:06:48 PM ET
    $EZFL
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form SC 13D/A filed by EzFill Holdings Inc. (Amendment)

    SC 13D/A - EzFill Holdings Inc (0001817004) (Subject)

    6/10/24 9:15:04 AM ET
    $EZFL
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $AIRI
    $EZFL
    $FPAY
    $HBIO
    Financials

    Live finance-specific insights

    View All

    Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas

    Reports preliminary fourth quarter revenue in line with guidance, gross margin at high end of guidance, and strong year over year adjusted EBITDA performance Expects year over year revenue growth and mid-to high-single-digit EBITDA growth in 2026Outlines strategy focused on positioning the company as a leader in the growing translational science tools market while expanding consumables revenue and improving operational performance HOLLISTON, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience"), a global leader in life science research tools, today announced preliminary financial results for the fourth quarter ended Decembe

    2/10/26 7:30:00 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Air Industries Group Announces Solid Financial Results for the Three and Nine Months Ended September 30, 2025

    Air Industries Group ("Air Industries") (NYSE:AIRI), a leading manufacturer of precision components and assemblies for large aerospace and defense prime contractors, today announced Financial Results for the Three and Nine months ended September 30, 2025. Third Quarter Results Net sales for the three months ended September 30, 2025 were $10.3 million and Adjusted EBITDA (a Non-GAAP) financial measure was $1.3 million. Other financial metrics reported were: Gross profit for the three months ended September 30, 2025 was $2.3 million. Gross profit as a percentage of sales was 22.3%. Operating expenses for the three months ended September 30, 2025 were $2.0 million, increasing $105

    11/14/25 4:30:00 PM ET
    $AIRI
    Military/Government/Technical
    Industrials

    Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET

    HOLLISTON, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) will announce its financial results for the quarter ended September 30, 2025, before the market opens on November 6, 2025, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.  Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number.  Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here. Financial information presented on the call, including the earnings release and a related slide present

    10/30/25 8:00:00 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials